TriSalus Life Sciences (TLSI) Competitors $5.62 +0.12 (+2.18%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$5.61 -0.01 (-0.20%) As of 03/28/2025 04:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLSI vs. BFLY, IRMD, AVNS, BBNX, SIBN, KIDS, TMCI, DCTH, NPCE, and NYXHShould you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Butterfly Network (BFLY), Iradimed (IRMD), Avanos Medical (AVNS), Beta Bionics (BBNX), SI-BONE (SIBN), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), NeuroPace (NPCE), and Nyxoah (NYXH). These companies are all part of the "medical equipment" industry. TriSalus Life Sciences vs. Butterfly Network Iradimed Avanos Medical Beta Bionics SI-BONE OrthoPediatrics Treace Medical Concepts Delcath Systems NeuroPace Nyxoah Butterfly Network (NYSE:BFLY) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership, community ranking and risk. Which has higher valuation & earnings, BFLY or TLSI? TriSalus Life Sciences has lower revenue, but higher earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioButterfly Network$82.06M7.00-$133.70M-$0.33-7.16TriSalus Life Sciences$26.89M6.37-$59.04M-$2.49-2.26 Does the media refer more to BFLY or TLSI? In the previous week, TriSalus Life Sciences had 6 more articles in the media than Butterfly Network. MarketBeat recorded 10 mentions for TriSalus Life Sciences and 4 mentions for Butterfly Network. TriSalus Life Sciences' average media sentiment score of 0.77 beat Butterfly Network's score of 0.61 indicating that TriSalus Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TriSalus Life Sciences 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, BFLY or TLSI? Butterfly Network has a beta of 2.48, meaning that its share price is 148% more volatile than the S&P 500. Comparatively, TriSalus Life Sciences has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Does the MarketBeat Community prefer BFLY or TLSI? TriSalus Life Sciences received 7 more outperform votes than Butterfly Network when rated by MarketBeat users. Likewise, 100.00% of users gave TriSalus Life Sciences an outperform vote while only 70.00% of users gave Butterfly Network an outperform vote. CompanyUnderperformOutperformButterfly NetworkOutperform Votes770.00% Underperform Votes330.00% TriSalus Life SciencesOutperform Votes14100.00% Underperform VotesNo Votes Do analysts prefer BFLY or TLSI? Butterfly Network currently has a consensus price target of $3.00, indicating a potential upside of 26.90%. TriSalus Life Sciences has a consensus price target of $11.56, indicating a potential upside of 105.74%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts clearly believe TriSalus Life Sciences is more favorable than Butterfly Network.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Butterfly Network 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.20 Do institutionals and insiders hold more shares of BFLY or TLSI? 37.8% of Butterfly Network shares are held by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are held by institutional investors. 27.3% of Butterfly Network shares are held by insiders. Comparatively, 32.8% of TriSalus Life Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is BFLY or TLSI more profitable? Butterfly Network has a net margin of -129.25% compared to TriSalus Life Sciences' net margin of -206.24%. TriSalus Life Sciences' return on equity of 0.00% beat Butterfly Network's return on equity.Company Net Margins Return on Equity Return on Assets Butterfly Network-129.25% -42.68% -30.31% TriSalus Life Sciences -206.24%N/A -236.83% SummaryTriSalus Life Sciences beats Butterfly Network on 12 of the 19 factors compared between the two stocks. Remove Ads Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSI vs. The Competition Export to ExcelMetricTriSalus Life SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$171.37M$4.35B$5.63B$7.83BDividend YieldN/A32.64%4.57%4.00%P/E Ratio-2.2628.4223.3318.68Price / Sales6.3749.43388.4691.04Price / CashN/A51.0838.1634.64Price / Book-5.736.046.894.23Net Income-$59.04M$67.64M$3.20B$247.15M7 Day Performance-0.35%-4.90%-3.02%-2.17%1 Month Performance-2.43%-3.28%1.63%-5.68%1 Year Performance-42.36%8.83%9.74%-0.67% TriSalus Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSITriSalus Life Sciences3.5021 of 5 stars$5.62+2.2%$11.56+105.7%-42.4%$171.37M$26.89M-2.26106Earnings ReportAnalyst ForecastNews CoverageBFLYButterfly Network2.7206 of 5 stars$2.83+7.0%$3.00+6.2%+123.0%$686.26M$82.06M-6.14460IRMDIradimed4.865 of 5 stars$52.86+1.0%$72.00+36.2%+19.1%$672.12M$73.24M35.24110Positive NewsAVNSAvanos Medical2.6884 of 5 stars$14.41-1.8%N/A-29.9%$662.77M$687.80M42.374,040BBNXBeta BionicsN/A$14.85-1.7%$24.83+67.2%N/A$636.46M$53.03M0.00294Earnings ReportAnalyst RevisionNews CoverageSIBNSI-BONE3.8738 of 5 stars$14.82+1.1%$24.50+65.3%-14.2%$629.15M$167.18M-16.11350Short Interest ↑Positive NewsHigh Trading VolumeKIDSOrthoPediatrics4.1949 of 5 stars$24.86-0.4%$37.25+49.8%-15.2%$603.78M$204.73M-20.21200Positive NewsTMCITreace Medical Concepts2.5401 of 5 stars$8.69+5.3%$10.14+16.7%-35.2%$544.16M$209.36M-8.78250Short Interest ↓DCTHDelcath Systems3.2523 of 5 stars$13.96+1.7%$22.75+63.0%+175.7%$466.31M$37.21M-10.3460Positive NewsNPCENeuroPace3.0176 of 5 stars$12.30+2.3%$15.20+23.6%-10.2%$400.49M$79.91M-12.30170Short Interest ↑Gap UpHigh Trading VolumeNYXHNyxoah2.7363 of 5 stars$11.30-0.5%$15.25+35.0%-43.3%$384.88M$4.52M-6.04110Analyst ForecastShort Interest ↓Analyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies Butterfly Network Competitors Iradimed Competitors Avanos Medical Competitors Beta Bionics Competitors SI-BONE Competitors OrthoPediatrics Competitors Treace Medical Concepts Competitors Delcath Systems Competitors NeuroPace Competitors Nyxoah Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLSI) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
